Global Psoriatic Arthritis Treatment Drugs Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Treatment Drugs.
The Psoriatic Arthritis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Psoriatic Arthritis Treatment Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Psoriatic Arthritis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Psoriatic Arthritis Treatment Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Eli Lilly
- Roche
- Merck
- Novartis
- Abbvie
- Amgen
- Bristol Myers Squibb
- Celgene Corporation
- Janssen
- Bausch Health
- Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
- Disease-modifying Anti-rheumatic Drugs (DMARDs)
- Others
- Hospital
- Clinic
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.3 Corticosteroids
1.2.4 Disease-modifying Anti-rheumatic Drugs (DMARDs)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Treatment Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Psoriatic Arthritis Treatment Drugs Market Perspective (2018-2029)
2.2 Psoriatic Arthritis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Psoriatic Arthritis Treatment Drugs Historic Market Size by Region (2018-2023)
2.2.3 Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2024-2029)
2.3 Psoriatic Arthritis Treatment Drugs Market Dynamics
2.3.1 Psoriatic Arthritis Treatment Drugs Industry Trends
2.3.2 Psoriatic Arthritis Treatment Drugs Market Drivers
2.3.3 Psoriatic Arthritis Treatment Drugs Market Challenges
2.3.4 Psoriatic Arthritis Treatment Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue (2018-2023)
3.1.2 Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Psoriatic Arthritis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Treatment Drugs Revenue
3.4 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Treatment Drugs Revenue in 2022
3.5 Psoriatic Arthritis Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis Treatment Drugs Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PSORIATIC ARTHRITIS TREATMENT DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Type (2018-2023)
4.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2024-2029)
5 PSORIATIC ARTHRITIS TREATMENT DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Application (2018-2023)
5.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
6.2 North America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
6.4 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
7.2 Europe Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
7.4 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
8.2 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
9.2 Latin America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
9.4 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
10.2 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Psoriatic Arthritis Treatment Drugs Introduction
11.1.4 Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Psoriatic Arthritis Treatment Drugs Introduction
11.2.4 Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Psoriatic Arthritis Treatment Drugs Introduction
11.3.4 Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis Treatment Drugs Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Detail
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Psoriatic Arthritis Treatment Drugs Introduction
11.5.4 Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.5.5 Abbvie Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Psoriatic Arthritis Treatment Drugs Introduction
11.6.4 Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Detail
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Introduction
11.7.4 Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Detail
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Psoriatic Arthritis Treatment Drugs Introduction
11.8.4 Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.8.5 Celgene Corporation Recent Development
11.9 Janssen
11.9.1 Janssen Company Detail
11.9.2 Janssen Business Overview
11.9.3 Janssen Psoriatic Arthritis Treatment Drugs Introduction
11.9.4 Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.9.5 Janssen Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Detail
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Psoriatic Arthritis Treatment Drugs Introduction
11.10.4 Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.10.5 Bausch Health Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.3 Corticosteroids
1.2.4 Disease-modifying Anti-rheumatic Drugs (DMARDs)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Treatment Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Psoriatic Arthritis Treatment Drugs Market Perspective (2018-2029)
2.2 Psoriatic Arthritis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Psoriatic Arthritis Treatment Drugs Historic Market Size by Region (2018-2023)
2.2.3 Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2024-2029)
2.3 Psoriatic Arthritis Treatment Drugs Market Dynamics
2.3.1 Psoriatic Arthritis Treatment Drugs Industry Trends
2.3.2 Psoriatic Arthritis Treatment Drugs Market Drivers
2.3.3 Psoriatic Arthritis Treatment Drugs Market Challenges
2.3.4 Psoriatic Arthritis Treatment Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue (2018-2023)
3.1.2 Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Psoriatic Arthritis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Treatment Drugs Revenue
3.4 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Treatment Drugs Revenue in 2022
3.5 Psoriatic Arthritis Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis Treatment Drugs Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PSORIATIC ARTHRITIS TREATMENT DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Type (2018-2023)
4.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2024-2029)
5 PSORIATIC ARTHRITIS TREATMENT DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Application (2018-2023)
5.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
6.2 North America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
6.4 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
7.2 Europe Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
7.4 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
8.2 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
9.2 Latin America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
9.4 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size (2018-2029)
10.2 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Psoriatic Arthritis Treatment Drugs Introduction
11.1.4 Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Psoriatic Arthritis Treatment Drugs Introduction
11.2.4 Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Psoriatic Arthritis Treatment Drugs Introduction
11.3.4 Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis Treatment Drugs Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Detail
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Psoriatic Arthritis Treatment Drugs Introduction
11.5.4 Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.5.5 Abbvie Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Psoriatic Arthritis Treatment Drugs Introduction
11.6.4 Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Detail
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Introduction
11.7.4 Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Detail
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Psoriatic Arthritis Treatment Drugs Introduction
11.8.4 Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.8.5 Celgene Corporation Recent Development
11.9 Janssen
11.9.1 Janssen Company Detail
11.9.2 Janssen Business Overview
11.9.3 Janssen Psoriatic Arthritis Treatment Drugs Introduction
11.9.4 Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.9.5 Janssen Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Detail
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Psoriatic Arthritis Treatment Drugs Introduction
11.10.4 Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
11.10.5 Bausch Health Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-modifying Anti-rheumatic Drugs (DMARDs)
Table 5. Key Players of Others
Table 6. Global Psoriatic Arthritis Treatment Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2018-2023)
Table 10. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2024-2029)
Table 12. Psoriatic Arthritis Treatment Drugs Market Trends
Table 13. Psoriatic Arthritis Treatment Drugs Market Drivers
Table 14. Psoriatic Arthritis Treatment Drugs Market Challenges
Table 15. Psoriatic Arthritis Treatment Drugs Market Restraints
Table 16. Global Psoriatic Arthritis Treatment Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Psoriatic Arthritis Treatment Drugs Market Share by Players (2018-2023)
Table 18. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2022)
Table 19. Ranking of Global Top Psoriatic Arthritis Treatment Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriatic Arthritis Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Psoriatic Arthritis Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriatic Arthritis Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Psoriatic Arthritis Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Psoriatic Arthritis Treatment Drugs Product
Table 51. Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche Psoriatic Arthritis Treatment Drugs Product
Table 56. Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Psoriatic Arthritis Treatment Drugs Product
Table 61. Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Psoriatic Arthritis Treatment Drugs Product
Table 66. Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Abbvie Company Detail
Table 69. Abbvie Business Overview
Table 70. Abbvie Psoriatic Arthritis Treatment Drugs Product
Table 71. Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 72. Abbvie Recent Development
Table 73. Amgen Company Detail
Table 74. Amgen Business Overview
Table 75. Amgen Psoriatic Arthritis Treatment Drugs Product
Table 76. Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Bristol Myers Squibb Company Detail
Table 79. Bristol Myers Squibb Business Overview
Table 80. Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Product
Table 81. Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 82. Bristol Myers Squibb Recent Development
Table 83. Celgene Corporation Company Detail
Table 84. Celgene Corporation Business Overview
Table 85. Celgene Corporation Psoriatic Arthritis Treatment Drugs Product
Table 86. Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 87. Celgene Corporation Recent Development
Table 88. Janssen Company Detail
Table 89. Janssen Business Overview
Table 90. Janssen Psoriatic Arthritis Treatment Drugs Product
Table 91. Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 92. Janssen Recent Development
Table 93. Bausch Health Company Detail
Table 94. Bausch Health Business Overview
Table 95. Bausch Health Psoriatic Arthritis Treatment Drugs Product
Table 96. Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 97. Bausch Health Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 1. Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-modifying Anti-rheumatic Drugs (DMARDs)
Table 5. Key Players of Others
Table 6. Global Psoriatic Arthritis Treatment Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2018-2023)
Table 10. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2024-2029)
Table 12. Psoriatic Arthritis Treatment Drugs Market Trends
Table 13. Psoriatic Arthritis Treatment Drugs Market Drivers
Table 14. Psoriatic Arthritis Treatment Drugs Market Challenges
Table 15. Psoriatic Arthritis Treatment Drugs Market Restraints
Table 16. Global Psoriatic Arthritis Treatment Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Psoriatic Arthritis Treatment Drugs Market Share by Players (2018-2023)
Table 18. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2022)
Table 19. Ranking of Global Top Psoriatic Arthritis Treatment Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriatic Arthritis Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Psoriatic Arthritis Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriatic Arthritis Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Psoriatic Arthritis Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Psoriatic Arthritis Treatment Drugs Product
Table 51. Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche Psoriatic Arthritis Treatment Drugs Product
Table 56. Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Psoriatic Arthritis Treatment Drugs Product
Table 61. Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Psoriatic Arthritis Treatment Drugs Product
Table 66. Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Abbvie Company Detail
Table 69. Abbvie Business Overview
Table 70. Abbvie Psoriatic Arthritis Treatment Drugs Product
Table 71. Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 72. Abbvie Recent Development
Table 73. Amgen Company Detail
Table 74. Amgen Business Overview
Table 75. Amgen Psoriatic Arthritis Treatment Drugs Product
Table 76. Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Bristol Myers Squibb Company Detail
Table 79. Bristol Myers Squibb Business Overview
Table 80. Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Product
Table 81. Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 82. Bristol Myers Squibb Recent Development
Table 83. Celgene Corporation Company Detail
Table 84. Celgene Corporation Business Overview
Table 85. Celgene Corporation Psoriatic Arthritis Treatment Drugs Product
Table 86. Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 87. Celgene Corporation Recent Development
Table 88. Janssen Company Detail
Table 89. Janssen Business Overview
Table 90. Janssen Psoriatic Arthritis Treatment Drugs Product
Table 91. Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 92. Janssen Recent Development
Table 93. Bausch Health Company Detail
Table 94. Bausch Health Business Overview
Table 95. Bausch Health Psoriatic Arthritis Treatment Drugs Product
Table 96. Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2018-2023) & (US$ Million)
Table 97. Bausch Health Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Psoriatic Arthritis Treatment Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Psoriatic Arthritis Treatment Drugs Market Share by Type: 2022 VS 2029
Figure 3. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 4. Corticosteroids Features
Figure 5. Disease-modifying Anti-rheumatic Drugs (DMARDs) Features
Figure 6. Others Features
Figure 7. Global Psoriatic Arthritis Treatment Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Psoriatic Arthritis Treatment Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Psoriatic Arthritis Treatment Drugs Report Years Considered
Figure 13. Global Psoriatic Arthritis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Psoriatic Arthritis Treatment Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Psoriatic Arthritis Treatment Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Psoriatic Arthritis Treatment Drugs Market Share by Players in 2022
Figure 17. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue in 2022
Figure 19. North America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 21. United States Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 25. Germany Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Share by Region (2018-2029)
Figure 33. China Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 41. Mexico Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 45. Turkey Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 49. Merck Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 51. Abbvie Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 53. Bristol Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 54. Celgene Corporation Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 55. Janssen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 56. Bausch Health Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global Psoriatic Arthritis Treatment Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Psoriatic Arthritis Treatment Drugs Market Share by Type: 2022 VS 2029
Figure 3. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 4. Corticosteroids Features
Figure 5. Disease-modifying Anti-rheumatic Drugs (DMARDs) Features
Figure 6. Others Features
Figure 7. Global Psoriatic Arthritis Treatment Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Psoriatic Arthritis Treatment Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Psoriatic Arthritis Treatment Drugs Report Years Considered
Figure 13. Global Psoriatic Arthritis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Psoriatic Arthritis Treatment Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Psoriatic Arthritis Treatment Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Psoriatic Arthritis Treatment Drugs Market Share by Players in 2022
Figure 17. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue in 2022
Figure 19. North America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 21. United States Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 25. Germany Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Share by Region (2018-2029)
Figure 33. China Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 41. Mexico Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Share by Country (2018-2029)
Figure 45. Turkey Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 49. Merck Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 51. Abbvie Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 53. Bristol Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 54. Celgene Corporation Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 55. Janssen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 56. Bausch Health Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
